Press "Enter" to skip to content

New patent for Global Blood drug OXBRYTA

2
Copyright © DrugPatentWatch. Originally published at New patent for Global Blood drug OXBRYTA

Annual Drug Patent Expirations for OXBRYTA
Annual Drug Patent Expirations for OXBRYTA

Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are six patents protecting this drug.

This drug has one hundred and sixty-three patent family members in thirty-two countries.

The generic ingredient in OXBRYTA is voxelotor. Additional details are available on the voxelotor profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Global Blood drug OXBRYTA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!